INFLUVAC Tetra 0.5 ml susp inj 15 µg 1 pce

7680680870112 CH-68087 J07BB02
INFLUVAC Tetra 0.5 ml susp inj 15 µg 1 pce
INFLUVAC Tetra 0.5 ml susp inj 15 µg 1 pce
INFLUVAC Tetra 0.5 ml susp inj 15 µg 1 pce
1 / 3
google

Details

Product number
-
CPT
-
Packaging group
-
Unit
-

Official Swissmedic V2 data

Additional information from the official database

Detailed composition

Substance Quantity Type Category
haemagglutininum influenzae A (H1N1)
15.0 UG Substance Wirkstoff (Principe actif)
haemagglutininum influenzae A (H3N2)
15.0 UG Substance Wirkstoff (Principe actif)
haemagglutininum influenzae B
15.0 UG Substance Wirkstoff (Principe actif)
haemagglutininum influenzae B
15.0 UG Substance Wirkstoff (Principe actif)
kalii chloridum
- Substance HNIDK
kalii dihydrogenophosphas
- Substance HNIDK
dinatrii phosphas dihydricus
- Substance HNIDK
natrii chloridum
- Substance HNIDK
calcii chloridum dihydricum
- Substance HNIDK
magnesii chloridum hexahydricum
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK
natrium
2.01 MG Substance HBESI
kalium
0.08 MG Substance HBESI
cetrimidum
- Substance RESI
formaldehydum
- Substance RESI
gentamicini sulfas
- Substance RESI
polysorbatum 80
- Substance RESI
ovalbuminum
- Substance HNIDK

Authorization holder

Viatris Pharma GmbH

6312 Steinhausen

Authorization information

Swissmedic authorization number
68087
Drug name
Influvac Tetra, Injektionssuspension
Galenic form
SUPA
ATC Code
J07BB02
Authorization status
Z
Dispensation category
B
First authorization
28/10/2020
Authorization expiration date
31/12/9999
IT number
08.08.
Domain
Human medicine
Field of application
aktive Immunisierung gegen Influenza, ab 6 Monaten

Packaging details

Description (FR)
INFLUVAC Tetra 0.5 ml susp inj 15 µg 1 pce
Description (DE)
INFLUVAC Tetra 0.5 ml Inj Susp 15 µg 1 Stk
Market launch
19/05/2025
Narcotic (BTM)
No

Other packaging sizes

INFLUVAC TETRA susp inj 2024/25 ser pré 0.5 ml
1 FESP
View
INFLUVAC TETRA susp inj 2024/25 10 ser pré 0.5 ml
10 FESP
View
Buy us a coffee Explore the data